A*STAR researchers discover a mechanism that fires up the metabolism of cancer-killing immune cells, paving the way for future cancer immunotherapies.
A novel polymer improves the effectiveness of chemotherapeutics against drug-resistant tumors.
Just because a molecular target resides inside a cancer cell does not mean that it cannot be targeted by antibodies, says Qi Zeng, founder of A*STAR spin-off company Intra-ImmuSG.
A*STAR scientists have identified a microRNA that can potentially be targeted for the treatment of triple-negative breast cancer.
A component of green tea can help deliver drugs to tumors in the body
Growing models of patients’ tumors in dishes will allow doctors to optimize individual treatments
reveal why certain cancer therapeutics may bind — or fail to bind — to mutant proteins